Just Launched! CCD Integration

August 24, 2017

CSS is excited to announce that we have just launched our Continuity of Care Document (CCD) Integration. CCD Integration moves CSS and MTMPathTM significantly along the interoperability path.  With the new CCD Integration functionality, medication and care management clinicians using the MTMPathTM platform can now integrate with any physician and hospital electronic record system to consume CCD documents and effortlessly build a patient profile for medication management review.  CCD integration: Allows for robust therapy gap identification Reduces the administrative burden of data entry and maximizes valuable pharmacist time Allows clinic based pharmacists to significantly scale their medication management efforts over large […]

MTM Pilot Audit Summary of Key Points

June 27, 2017

CSS has put together a list of key points and associated feedback that we gained from: Attending the CMS Spring Conference’s MTM Pilot Audit panel discussion Our direct experience with our first CMS MTM Pilot/Program Audit. 2017 CMS Spring Conference MTM Pilot Audit Panel Discussion FINAL Summary May 2017 We are prepared to work closely with you to support any future MTM audit and hope you find this information useful. If you have any questions pertaining to this summary, please feel free to contact us.

The MTM Boat

August 28, 2017

Preparing for Biosimilars

June 26, 2017

Manufacturers of biologic drugs over the past few years have been “pulling out all the stops” to difficult for less expensive biosimilar products to come to market.  Biologic drug manufactures have used tactics like patent infringement suits to delay the availability of biosimilars. Note: Biosimilars are the “generic” equivalent of a biologic drug.  Unlike traditional drugs, biologics are made from living cells and cannot be copied exactly to make generic versions. They are used to treat a range of conditions, including Crohn’s disease, ulcerative colitis, rheumatoid arthritis, plaque psoriasis, breast cancer and diabetes.  The U.S. Supreme Court, in a recent […]

Patient Acceptance of Pharmacist Run Transition of Care Service

June 11, 2017

A recent article in Innovations in Pharmacy (http://pubs.lib.umn.edu/cgi/viewcontent.cgi?article=1310&context=innovations) describes a unique pharmacy based transition of care service.  Kowalski et. al. describe a transitions of care collaboration between Streu’s Pharmacy Bay Natural (an independent community pharmacy in Green Bay, WI) and Bellin Hospital.   Streu’s piloted a transition of care service for the cardiac unit at Bellin. Getting Patients Into Transitions Care Patients in the cardiac unit were eligible for the transition service if they were a Wisconsin resident, had moderate to high risk for readmission and were anticipated to be discharged to their homes (vs. an inpatient rehabilitation or long-term care […]

Drug Related Readmissions

May 17, 2017

A recent study in the March 2017 edition of the Journal of Patient Safety (http://insights.ovid.com/crossref?an=01209203-900000000-99520) highlights the extent to which avoidable medication errors impact early readmissions. In this study, the authors evaluated a  random sample of 534 potentially avoidable 30-day readmissions from 10,275 consecutive discharges.  They found that 70 (13.1%) of readmission were partially or predominantly due to adverse drug events (ADEs) and of these they rated 58 (82.9%) as serious ADEs.  Strikingly, 65 (92.9%) of the ADEs were confirmed to be preventable.  The preventable ADEs were classified as inappropriate prescribing (34 cases, 48.6%), misprescribing (19 cases, 27.1%), underprescribing (8 cases, […]

Just Launched: Program Association with Assessments & More

April 8, 2017

We’re pleased to announce the upcoming release of several exciting enhancement to MTMPath. Program Selection in the Assessment section When you log in to MTMPath, you’ll see a new option when you go to the assessments section within a patient’s chart. This new option requires the selection of a program (known to some as an eligibility) before you can complete a given assessment for a patient. This enhancement will enable us to better track intent of an assessment, as we improve support for multiple concurrent programs. Additionally, having a direct association of an assessment with a program will enable us […]

Elevate Pharmacy Virtual Summit

March 10, 2017

From April 5-9th, 2017 the Elevate Pharmacy Virtual Summit will present the industry’s first ever completely web-based pharmacy conference experience.  This free Summit was specifically developed for entrepreneurial-minded student pharmacists, independent pharmacy owners and private practice consultants.  This summit is specifically designed for entrepreneurial pharmacists looking to make their mark with enhanced clinical pharmacy services, be sure to watch the short introductory video above to learn what we’re all about. Then, reserve your spot and get ready to be inspired!   This event features presentations by twenty-two independent thinkers who are succeeding differently in the healthcare space.  You’ll hear what works […]

Just Launched: Program Selection & Assessment Type

March 11, 2017

We’re excited to announce several new enhancements to MTMPath which will enable us to better manage your program data. Program Selection on Contact Info section of the Patient Chart From now on, when you create a contact record for a Patient, you’ll be required to select an associated program. This new drop-down box will populate with all the programs for which a patient is currently actively enrolled.If the patient is only enrolled in one program, that program will automatically be selected. If they’re not active in any particular program or the contact is not related to the available Programs in the […]

CMS Advance Call Letter, Impact on MTM Program Submission

March 4, 2017

CMS recently released the 2018 Advance Call Letter for Medicare Part D Programs (https://www.cms.gov/Medicare/Health-Plans/MedicareAdvtgSpecRateStats/Downloads/Advance2018.pdf).  Submissions for the Medication Therapy Management (MTM) program are due May 1, 2017.  The MTM program is the perfect place to gain experience with and understand the status of new quality metrics.  Including in some form (either as part of your program identification or design), the quality metrics entering Display or STAR status benefits a Medicare Advantage Program by: Improving the value (ROI) of MTM interactions Provides the Plan with advanced understanding of the status of a population Prepares the plan to address the quality metric at […]